Yes, you're talking BS. The company continues to make steady progress through multiple late stage clinical trials. If that continues, significant share price appreciation is simply a matter of time. I'm willing to wait, and am happy that management doesn't concern themselves with short term nonsense.
Oh look, a kitty!!!!!